Search Results Search Sort by RelevanceMost Recent Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553. AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600. Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168. Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen. Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602. Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603. AMA Code Says Dec 2002 CEJA to Present Three Reports with Recommendations to House of Delegates Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):361-362. doi: 10.1001/virtualmentor.2002.4.12.code1-0212. Pagination Current page 1 Page 2 Page 3 Page 4 Page 5 Next page Next › Last page Last »
Podcast May 2019 Ethics Talk: When and How Should ECMO Be Initiated and Removed? When should ECMO be started and stopped? This month’s Ethics Talk explores ethical challenges of ECMO use in end-of-life care.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Case and Commentary Jul 2019 When There’s No One to Whom an Error Can Be Disclosed, How Should an Error Be Handled? Ryan G. Chiu When a patient is incompetent and unrepresented, alternative strategies must be implemented to document and try to rectify an error. AMA J Ethics. 2019;21(7):E553-558. doi: 10.1001/amajethics.2019.553.
AMA Code Says Jul 2019 AMA Code of Medical Ethics’ Opinions Related to Unrepresented Patients Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics discusses situations in which a surrogate is needed but not available to make health care decisions for a patient. AMA J Ethics. 2019;21(7):E600-602. doi: 10.1001/amajethics.2019.600.
Personal Narrative Feb 2020 Six Tips for Giving Good Health Care to Anyone With a Cervix Ryan K. Sallans, MA Eliminating cervical cancer inequality means transmen need regular, unimpeded access to regular Pap screening. AMA J Ethics. 2020;22(2):E168-175. doi: 10.1001/amajethics.2020.168.
Podcast Feb 2020 Ethics Talk: Providing Compassionate Care for Transmen Author Ryan Sallans discusses his experience accessing health care and suggests how to take good gynecological care of transmen.
Case and Commentary Feb 2016 How to Communicate Clearly about Brain Death and First-Person Consent to Donate Stuart J. Youngner, MD Despite clear donor consent, health professionals must communicate clearly about death to family members to avoid confusion. AMA J Ethics. 2016;18(2):108-114. doi: 10.1001/journalofethics.2017.18.2.ecas2-1602.
Policy Forum Mar 2016 Medical Malpractice Reform: Historical Approaches, Alternative Models, and Communication and Resolution Programs Joseph S. Kass, MD, JD and Rachel V. Rose, JD, MBA Alternatives to suing could help open communication between injured patients and clinicians. AMA J Ethics. 2016;18(3):299-310. doi: 10.1001/journalofethics.2016.18.3.pfor6-1603.
AMA Code Says Dec 2002 CEJA to Present Three Reports with Recommendations to House of Delegates Audiey Kao, MD, PhD Virtual Mentor. 2002;4(12):361-362. doi: 10.1001/virtualmentor.2002.4.12.code1-0212.